Literature DB >> 10852777

A model of obstructive sleep apnea in normal humans. Role of the upper airway.

E D King1, C P O'Donnell, P L Smith, A R Schwartz.   

Abstract

We determined whether upper airway obstruction in normal individuals with intact reflexes could produce the syndrome of obstructive sleep apnea. Upper airway obstruction was produced in 12 normal individuals by lowering nasal pressure to -10 cm H(2)O during sleep. Full night polysomnography was performed during two consecutive nights of sleep with subatmospheric nasal pressure and compared with control nights before and after the negative pressure nights. We found that the application of negative pressure was associated with the development of recurrent obstructive apneas (non-REM-disordered breathing rate, 32.6 +/- 34.8 and 37.8 +/- 29.1 events/h during each of two negative pressure nights; p < 0.001) that were associated with oxyhemoglobin desaturation, arousals from sleep, and alterations in sleep stage distribution. Moreover, the median daytime sleep latency after two nights of sleep with subatmospheric pressure fell from 6.9 +/- 1.1 to 3.4 +/- 0.6 min, and rose significantly again to 8.1 +/- 1.5 min (p < 0.03) after the control night following subatmospheric pressure nights. Our findings suggest that a decrease in the pharyngeal transmural pressure alone is a sufficient condition for the production of the sleep apnea syndrome in normal individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852777     DOI: 10.1164/ajrccm.161.6.9904096

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

Review 1.  The pathogenesis of obstructive sleep apnea.

Authors:  Luu V Pham; Alan R Schwartz
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 2.  Adult obstructive sleep apnea: pathophysiology and diagnosis.

Authors:  Susheel P Patil; Hartmut Schneider; Alan R Schwartz; Philip L Smith
Journal:  Chest       Date:  2007-07       Impact factor: 9.410

3.  CrossTalk proposal: the human upper airway does behave like a Starling resistor during sleep.

Authors:  Alan R Schwartz; Philip L Smith
Journal:  J Physiol       Date:  2013-05-01       Impact factor: 5.182

4.  Pharyngeal collapsibility during sleep is elevated in insulin-resistant females with morbid obesity.

Authors:  Oscar L Llanos; Panagis Galiatsatos; Edmarie Guzmán-Vélez; Susheel P Patil; Philip L Smith; Thomas Magnuson; Michael Schweitzer; Kimberley Steele; Vsevolod Y Polotsky; Alan R Schwartz
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

5.  Sleep apnea and pesticide exposure in a study of US farmers.

Authors:  Brittney O Baumert; Megan Ulmer Carnes; Jane A Hoppin; Chandra L Jackson; Dale P Sandler; Laura Beane Freeman; Paul K Henneberger; David M Umbach; Srishti Shrestha; Stuart Long; Stephanie J London
Journal:  Sleep Health       Date:  2017-09-28

Review 6.  Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.

Authors:  Leszek Kubin
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

7.  A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome.

Authors:  D Passali; G Corallo; A Petti; M Longini; F M Passali; G Buonocore; L M Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-12       Impact factor: 2.124

8.  Society of anesthesia and sleep medicine: proceedings of 2012 annual meeting.

Authors:  Roop Kaw; Babak Mokhlesi; Frances Chung; Peter Gay; Norman Bolden; David Hillman
Journal:  Sleep Breath       Date:  2013-05-15       Impact factor: 2.816

Review 9.  Obesity and upper airway control during sleep.

Authors:  Alan R Schwartz; Susheel P Patil; Samuel Squier; Hartmut Schneider; Jason P Kirkness; Philip L Smith
Journal:  J Appl Physiol (1985)       Date:  2009-10-29

Review 10.  Rhinitis and sleep apnea.

Authors:  Maria T Staevska; Mariana A Mandajieva; Vasil D Dimitrov
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.